225 related articles for article (PubMed ID: 22292751)
1. Introduction: MMPs, ADAMs/ADAMTSs research products to achieve big dream.
Okazaki I; Nabeshima K
Anticancer Agents Med Chem; 2012 Sep; 12(7):688-706. PubMed ID: 22292751
[TBL] [Abstract][Full Text] [Related]
2. Comparative gene expression profiling of ADAMs, MMPs, TIMPs, EMMPRIN, EGF-R and VEGFA in low grade meningioma.
Rooprai HK; Martin AJ; King A; Appadu UD; Jones H; Selway RP; Gullan RW; Pilkington GJ
Int J Oncol; 2016 Dec; 49(6):2309-2318. PubMed ID: 27779709
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases (MMPs) in health and disease: an overview.
Malemud CJ
Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
[TBL] [Abstract][Full Text] [Related]
4. [The role of matrixmetalloproteinases in the tumor growth and metastasis].
Velinov N; Poptodorov G; Gabrovski N; Gabrovski S
Khirurgiia (Sofiia); 2010; (1):44-9. PubMed ID: 21972705
[TBL] [Abstract][Full Text] [Related]
5. Differential expressions of matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs and their endogenous inhibitors among histologic subtypes of lung cancers.
Hida Y; Hamada J
Anticancer Agents Med Chem; 2012 Sep; 12(7):744-52. PubMed ID: 22292754
[TBL] [Abstract][Full Text] [Related]
6. Molecularly targeted anti-cancer drugs inhibit the invasion and metastasis of hepatocellular carcinoma by regulating the expression of MMP and TIMP gene families.
He XX; Shi LL; Qiu MJ; Li QT; Wang MM; Xiong ZF; Yang SL
Biochem Biophys Res Commun; 2018 Oct; 504(4):878-884. PubMed ID: 30219235
[TBL] [Abstract][Full Text] [Related]
7. Differential gene expression profiling of metalloproteinases and their inhibitors: a comparison between bovine intervertebral disc nucleus pulposus cells and articular chondrocytes.
Cui Y; Yu J; Urban JP; Young DA
Spine (Phila Pa 1976); 2010 May; 35(11):1101-8. PubMed ID: 20473119
[TBL] [Abstract][Full Text] [Related]
8. The behavior of matrix metalloproteinases and their inhibitors in colorectal cancer.
Herszényi L; Hritz I; Lakatos G; Varga MZ; Tulassay Z
Int J Mol Sci; 2012 Oct; 13(10):13240-63. PubMed ID: 23202950
[TBL] [Abstract][Full Text] [Related]
9. Expression profiles and clinical correlations of degradome components in the tumor microenvironment of head and neck squamous cell carcinoma.
Stokes A; Joutsa J; Ala-Aho R; Pitchers M; Pennington CJ; Martin C; Premachandra DJ; Okada Y; Peltonen J; Grénman R; James HA; Edwards DR; Kähäri VM
Clin Cancer Res; 2010 Apr; 16(7):2022-35. PubMed ID: 20305301
[TBL] [Abstract][Full Text] [Related]
10. Role of matrix metalloproteinases and their inhibitors in tumor invasion and metastasis.
Khasigov PZ; Podobed OV; Gracheva TS; Salbiev KD; Grachev SV; Berezov TT
Biochemistry (Mosc); 2003 Jul; 68(7):711-7. PubMed ID: 12946252
[TBL] [Abstract][Full Text] [Related]
11. Novel strategies for hepatocellular carcinoma based on MMPs science.
Okazaki I; Inagaki Y
Anticancer Agents Med Chem; 2012 Sep; 12(7):753-63. PubMed ID: 22292750
[TBL] [Abstract][Full Text] [Related]
12. The Many Facets of Metzincins and Their Endogenous Inhibitors: Perspectives on Ovarian Cancer Progression.
Escalona RM; Chan E; Kannourakis G; Findlay JK; Ahmed N
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393911
[TBL] [Abstract][Full Text] [Related]
13. Unripe Rubus coreanus Miquel suppresses migration and invasion of human prostate cancer cells by reducing matrix metalloproteinase expression.
Kim Y; Lee SM; Kim JH
Biosci Biotechnol Biochem; 2014; 78(8):1402-11. PubMed ID: 25130744
[TBL] [Abstract][Full Text] [Related]
14. Genetic patterns of metalloproteinases and their tissular inhibitors - clinicopathologic and prognostic significance in colorectal cancer.
Surlin V; Ioana M; Pleşea IE
Rom J Morphol Embryol; 2011; 52(1 Suppl):231-6. PubMed ID: 21424059
[TBL] [Abstract][Full Text] [Related]
15. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
16. Relationship between matrix metalloproteinases and the occurrence and development of ovarian cancer.
Zhang Y; Chen Q
Braz J Med Biol Res; 2017 May; 50(6):e6104. PubMed ID: 28538838
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases and their role in pancreatic cancer: a review of preclinical studies and clinical trials.
Bloomston M; Zervos EE; Rosemurgy AS
Ann Surg Oncol; 2002 Aug; 9(7):668-74. PubMed ID: 12167581
[TBL] [Abstract][Full Text] [Related]
18. Cobalt chloride-induced hypoxia modulates the invasive potential and matrix metalloproteinases of primary and metastatic breast cancer cells.
Fu OY; Hou MF; Yang SF; Huang SC; Lee WY
Anticancer Res; 2009 Aug; 29(8):3131-8. PubMed ID: 19661326
[TBL] [Abstract][Full Text] [Related]
19. Matrix Metalloproteinases: How Much Can They Do?
Ågren MS; Auf dem Keller U
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290531
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases in tumor invasion.
Johansson N; Ahonen M; Kähäri VM
Cell Mol Life Sci; 2000 Jan; 57(1):5-15. PubMed ID: 10949577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]